awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40291907-2B2726D1-5EC7-48F8-AD8B-523EFC747269
Q40291907-2B2726D1-5EC7-48F8-AD8B-523EFC747269
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40291907-2B2726D1-5EC7-48F8-AD8B-523EFC747269
Cost-effectiveness of combination daclatasvir-sofosbuvir for treatment of genotype 3 chronic hepatitis C infection in the United States.
P2860
Q40291907-2B2726D1-5EC7-48F8-AD8B-523EFC747269
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40291907-2B2726D1-5EC7-48F8-AD8B-523EFC747269
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
267f30ee7974257578a84d5b209e84188abf5af2
P2860
The economics of treating chronic hepatitis C patients with peginterferon alpha-2a (40 kDa) plus ribavirin presenting with persistently normal aminotransferase.